keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
A-1155463是一种高效选择性的BCL-XL 抑制剂,对 BCL-XL 具有皮摩尔的结合亲和力,在Molt-4细胞中的EC50值为70 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 483 | 现货 | ||
2 mg | ¥ 690 | 现货 | ||
5 mg | ¥ 970 | 现货 | ||
10 mg | ¥ 1,390 | 现货 | ||
25 mg | ¥ 2,560 | 现货 | ||
50 mg | ¥ 3,820 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,470 | 现货 |
产品描述 | A-1155463, a highly potent and selective BCL-XL inhibitor, shows picomolar binding affinity to BCL-XL, and >1000-fold weaker binding to BCL-2 and related proteins BCL-W(Ki=19 nM) and MCL-1(Ki>440 nM). |
靶点活性 | BCL-XL:<0.01 nM(Ki) |
体外活性 | A-1155463 disrupts BCL-XL-BIM but not BCL-2-BIM complexes in cells. A-1155463 kills BCL-XL-dependent Molt-4 cells (EC50=70 nM) but has no measurable cytotoxicity against BCL-2-dependent RS4;11 cells (EC50>5 mM). A-1155463 induces the hallmarks of apoptosis, as evidenced by the release of cytochrome c from mitochondria, caspase activation, and the accumulation of caspase-dependent sub-G0-G1 DNA content in BCL-XL-dependent H146 cells[2]. |
体内活性 | Following a single 5 mg/kg IP dose of A-1155463 in nontumor bearing SCID-Beige mice, platelet counts fall dramatically as measured at 6 h postdose and then rebound to normal levels within 72 h. Daily Dosing at 5 mg/kg IP to SCID-Beige mice that had been inoculated with BCL-XL-dependent H146 tumor cells for 14 days causes a statistically significant inhibition of tumor growth (maximum tumor growth inhibition = 44%), which is alleviated upon cessation of dosing[1]. |
激酶实验 | Recombinant p38 isoforms are activated by Mkk6(E) under the following conditions: p38 (100 ng/mL), Mkk6(E) (30 ng/mL), ATP (100 mM) are mixed in kinase buffer (25 mM Hepes, 25 mM b-glycerophosphate, 0.1 mM sodium orthovanadate, 25 mM MgCl2, 2.5 mM DTT, pH 7.4) and incubated for 30 min at 30°C. A typical assay reaction for Mnk1 activity contained Mnk1 (2 ng/mL), HA-eIF4E (10 ng/mL), ATP (300 mM) in kinase buffer. The reaction is started by addition of activated p38 (0.03-3 ng/mL) and stopped after 30 min at 30°C by addition of SDS loading buffer. Inhibitors of Mnk1 are identified under the same assay conditions, except that Mnk1 is pre-activated using active p38a before exposure to the substrate and inhibitors. |
细胞实验 | Cells are treated with increasing concentration of A-1155463. Cells are assayed for viability after 72 h using the CellTiter-Glo luminescent cell viability assay according to the manufacturer's protocol. Results are normalized to cells without treatment. EC50 is calculated using the GraphPad Prism software.(Only for Reference) |
动物实验 | Animal Models: SCID-Beige MiceFormulation: 5% DMSO, 10% EtOH, 20% Cremaphor ELP, and 65% D5WDosages: 5 mg/kgAdministration: i.p. |
别名 | A 1155463, A1155463, 醋酸艾塞那肽 |
分子量 | 669.79 |
分子式 | C35H32FN5O4S2 |
CAS No. | 1235034-55-5 |
keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (149.3 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 100 mg/mL (149.3 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 1.493 mL | 7.465 mL | 14.9301 mL | 37.3251 mL |
5 mM | 0.2986 mL | 1.493 mL | 2.986 mL | 7.465 mL | |
10 mM | 0.1493 mL | 0.7465 mL | 1.493 mL | 3.7325 mL | |
20 mM | 0.0747 mL | 0.3733 mL | 0.7465 mL | 1.8663 mL | |
50 mM | 0.0299 mL | 0.1493 mL | 0.2986 mL | 0.7465 mL | |
100 mM | 0.0149 mL | 0.0747 mL | 0.1493 mL | 0.3733 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
A-1155463 1235034-55-5 Apoptosis BCL Bcl-2 Family Inhibitor A 1155463 A1155463 醋酸艾塞那肽 inhibit inhibitor